You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 44 No. 7, July 1987 TABLE OF CONTENTS
  Archives
  •  Online Features
  LETTERS TO THE EDITOR
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Lupus Anticoagulant and Stroke

Steven R. Levine, MD; K. M. A. Welch, MD
Department of Neurology Kll Henry Ford Hospital 2799 W Grand Blvd Detroit, MI 48202

Arch Neurol. 1987;44(7):691.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—Tabachnik-Schor and Lipton's1 recent report of a case of nonvasculitic cerebral infarction associated with a lupuslike anticoagulant (LA) suggests that their case is the first without "other causes of vasculopathy." Several features of their patient's case do not appear to support their conclusion. Their patient's skin biopsy specimen revealed immune complexes "consistent with a diagnosis of a vasculitis such as systemic lupus erythematosus (SLE)." Further, they state that their patient's stroke was the "first manifestation of vasculitis in a patient with presumptive SLE."

Tabachnik-Schor and Lipton state that there are many mechanisms of stroke associated with SLE. Abnormalities of fibrinolysis may also contribute to stroke in SLE,2 and this was not specifically checked for in their patient. Further, cigarette smoking alone can significantly increase the risk of premature stroke3 and, thus, cannot be ignored as a concomitant stroke risk factor in their patient. . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1987 American Medical Association. All Rights Reserved.